China Securities Regulatory Commission

Securities / Derivatives

CSRC Addresses Lengthy Stock Suspensions in New Guidance

By Editors | 07/11/2018

China’s listed companies have historically used trading halts to prevent stock price declines during market stress, preventing investors from selling for long periods of time.

Securities / Derivatives

Shanghai Stock Exchange to Launch New Technology Board

By Manesh Samtani | 06/11/2018

Announced by President Xi Jinping, the new science and technology board will subject innovative enterprises to different profitability and ownership requirements.

Capital / Liquidity

China’s Listed Companies Receive Support from Brokers

By Editors | 05/11/2018

Eleven brokerages have contributed $3.7bn to help listed companies facing liquidity issues, while a new programme is launched to support corporate bond issuances.

Market Infrastructure

MAS, CSRC Enhance Cooperation on Capital Markets, Derivatives

By Editors | 01/11/2018

The derivatives MoU will enhance cross-border supervision and the development of futures markets, while staff exchanges will deepen ties between the agencies.

Market Infrastructure

StanChart Becomes First Foreign Bank with Custody Licence in China

By Editors | 30/10/2018

The CSRC has granted Standard Chartered Bank a domestic fund custody licence, which until now has been reserved for local institutions.

Market Infrastructure

Shinzo Abe’s Beijing Visit Paves Way for Financial Sector Cooperation

By Manesh Samtani | 29/10/2018

Forty years since the 1978 peace treaty marked by a series of MoUs between central banks, securities regulators, stock exchanges and industry bodies, among others.

Securities / Derivatives

China Formalises Measures to Support Markets, Private Enterprises

By Manesh Samtani | 23/10/2018

The measures include more funding to support bank lending to small firms and a broker-led fund to support listed companies facing forced liquidation of pledged shares, among others.

Securities / Derivatives

China’s Top Regulators Restore Market Confidence with Vow of Support

By Manesh Samtani | 22/10/2018

The PBOC, CBIRC and CSRC issued statements announcing new measures to support China’s market after equities fell to their lowest levels since May 2014.

Enforcement

Scandal-Hit Chinese Drug Maker Faces CSRC Fine

By Garima Chitkara | 17/10/2018

The CSRC’s 600,000 yuan fine on Changsheng Biotechnology for falsifying data for a rabies vaccine form a small part of the 9.1 billion yuan it will have to pay.